The Effect of the Emotional Freedom Technique Applied to Postmenopausal Women Before Probe Curettage on Pain, Anxiety and Vital Signs. (EFT-ANXIETY)

Kahramanmaraş Sütçü İmam University (KSU)

Status: Completed

Conditions: The Effect of Emotional Freedom Technique on Anxiety, Pain, and Vital Signs

Treatments: Behavioral: emotional freedom technique

Study type: Interventional

Funder types: Other

Identifiers

NCT07348068

KSU-MED-TRIAL-01

2024/109

Details and patient eligibility

About

The aim of the study is to examine the effect of the emotional freedom technique applied to postmenopausal women before the probe curettage procedure on pain, anxiety and vital signs.

Full description

In this experimentally designed study, it was aimed to examine the effect of the emotional freedom technique applied to postmenopausal women before the probe curettage procedure on pain, anxiety and vital signs.

Enrollment: 132 patients

Sex: Female

Ages: 18 to 75 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Those who are in menopause
• Do not have conditions such as infection, wound or scar in the tapping areas,
• Having no problem communicating in Turkish,
• Those who have not used any analgesic medication in the last 24 hours,
• Those who have not had probe curettage before,
• Volunteer to participate in the study,
• Not using any medication that directly affects vital signs,
• Does not have a disease that would cause problems in feeling pain,
• Not using antidepressants, anxiolytics and sedative agents.

Exclusion criteria

• • Those who are not in menopause

  • Women who have had probe curettage before
  • Their general condition deteriorates during the procedure or a different intervention is made with anesthesia,
  • Any complications developed during the procedure,
  • Those who experienced syncope during the procedure and the procedure was continued with general/local anesthesia,
  • Having a psychiatric problem,
  • Analgesic medication used during the procedure,
  • Having cognitive, affective, perceptual problems.

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

132 participants in 2 patient groups

EFT İNVERTİON GROUP

Experimental group

Description:

During the initial consultation, the Personal Information Form, SUE Scale, State Anxiety Scale (SAS), Visual Analog Scale (VAS), vital signs (blood pressure, heart rate, and peripheral oxygen saturation/SpO2) Monitoring Form will be administered. EFT, which lasts approximately 30-40 minutes, will be administered to women by the researcher. Second measurement: Immediately after EFT, the SUE Scale, State Anxiety Scale (SAS), Visual Analog Scale (VAS), and vital signs (blood pressure, heart rate, and peripheral oxygen saturation/SpO2) will be administered again. Following the second measurement, the probe curettage will be performed. Third measurement: During the procedure, the VAS and vital signs (blood pressure, heart rate, and peripheral oxygen saturation/SpO2) Monitoring Form will be administered. Fourth measurement: After the probe curettage, women will be given 2 minutes to rest. The Visual Analog Scale (VAS) and vital signs (blood pressure, heart rate, and peripheral oxygen satur

Treatment:

Behavioral: emotional freedom technique

control group

No Intervention group

Description:

During the initial consultation, the Personal Information Form, SUE Scale, State Anxiety Scale (SAS), Visual Analog Scale (VAS), vital signs (blood pressure, heart rate, and peripheral oxygen saturation/SpO2) Monitoring Form will be administered. Second measurement: The SUE Scale, State Anxiety Scale (SAS), Visual Analog Scale (VAS), and vital signs (blood pressure, heart rate, and peripheral oxygen saturation/SpO2) will be administered again simultaneously with the EFT group. Following the second measurement, a probe curettage will be performed. Third measurement: During the procedure, the VAS and vital signs (blood pressure, heart rate, and peripheral oxygen saturation/SpO2) Monitoring Form will be applied. Fourth measurement: After the probe curettage, women will be given 2 minutes to rest. The Visual Analog Scale (VAS) and vital signs (blood pressure, heart rate, and peripheral oxygen saturation/SpO2) Monitoring Form will be applied.